Mankind Pharma Q1 Profit Falls, Revenue Jumps

  Published 10 months ago

Mankind Pharma's Q1FY26 net profit fell 18.1% YoY, while revenue surged 24.5% with strong export and segment growth.

  • EBITDA rose 26% YoY to ₹847.6 crore; margin improved slightly to 23.7% on better operational efficiency.
  • Export revenue jumped 81.1% YoY to ₹469 crore, driven by BSV consolidation and base business expansion.
  • Consumer healthcare grew 15% YoY; e-commerce share rose to 11% with strong brand performance across key products.
You might like these

Voltas Stock Dips Amid Rain Impact, Brokerage Cuts

India Forex Reserves Hit $703bn in One Week

NMDC Iron Ore Production and Sales Report 2025

Cash Ur Drive Marketing IPO Success

Jubilant Cadista Clean Inspection

Voltas Shares Surge on Axis Direct 'Buy' Rating

India Eyes Equities Market Growth

News that matters the most ⚡